Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)
Titel:
Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)
Auteur:
De Miguel, Rosa Rial-Crestelo, David Dominguez-Dominguez, Lourdes Montejano, Rocío Esteban-Cantos, Andrés Aranguren-Rivas, Paula Stella-Ascariz, Natalia Bisbal, Otilia Bermejo-Plaza, Laura Garcia-Alvarez, Mónica Alejos, Belén Hernando, Asunción Santacreu-Guerrero, Mireia Cadiñanos, Julen Mayoral, Mario Castro, Juan Miguel Moreno, Victoria Martin-Carbonero, Luz Delgado, Rafael Rubio, Rafael Pulido, Federico Arribas, José Ramón